Ventricular arrhythmias and cerebrovascular events in the elderly using conventional and atypical antipsychotic medications.

[1]  M Alan Brookhart,et al.  Evaluating Short-Term Drug Effects Using a Physician-Specific Prescribing Preference as an Instrumental Variable , 2006, Epidemiology.

[2]  J. Avorn,et al.  Risk of death in elderly users of conventional vs. atypical antipsychotic medications. , 2005, The New England journal of medicine.

[3]  Lon S Schneider,et al.  Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. , 2005, JAMA.

[4]  C. Lyketsos,et al.  Antipsychotic drugs in dementia: what should be made of the risks? , 2005, JAMA.

[5]  V. Mor,et al.  Cerebrovascular events among elderly nursing home patients treated with conventional or atypical antipsychotics. , 2005, The Journal of clinical psychiatry.

[6]  V. Mor,et al.  Conventional and atypical antipsychotics and the risk of hospitalization for ventricular arrhythmias or cardiac arrest. , 2005, Archives of Internal Medicine.

[7]  H. Nasrallah,et al.  Lower mortality in geriatric patients receiving risperidone and olanzapine versus haloperidol: preliminary analysis of retrospective data. , 2004, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[8]  Johan van der Lei,et al.  Antipsychotics and the risk of sudden cardiac death. , 2004, Archives of internal medicine.

[9]  N. Herrmann,et al.  Atypical antipsychotics and risk of cerebrovascular accidents. , 2004, The American journal of psychiatry.

[10]  J. Miklossy.  Cerebral hypoperfusion induces cortical watershed microinfarcts which may further aggravate cognitive decline in Alzheimer's disease , 2003, Neurological research.

[11]  Robert F Reynolds,et al.  Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: cohort study using administrative data , 2002, BMJ : British Medical Journal.

[12]  G. Remington,et al.  How much are atypical antipsychotic agents being used, and do they reach the populations who need them? A Canadian experience. , 2002, Clinical therapeutics.

[13]  S. Ayis,et al.  Thioridazine and sudden unexplained death in psychiatric in-patients. , 2002, The British journal of psychiatry : the journal of mental science.

[14]  W A Ray,et al.  Antipsychotics and the risk of sudden cardiac death. , 2001, Archives of general psychiatry.

[15]  A H Glassman,et al.  Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death. , 2001, The American journal of psychiatry.

[16]  Laverty Sg,et al.  THIORIDAZINE HYDROCHLORIDE (MELLARIL): ITS EFFECT ON THE ELECTROCARDIOGRAM AND A REPORT OF TWO FATALITIES WITH ELECTROCARDIOGRAPHIC ABNORMALITIES. , 1963 .

[17]  G. Alexopoulos,et al.  Using antipsychotic agents in older patients. , 2004, The Journal of clinical psychiatry.